Results 91 to 100 of about 40,297 (296)
Botulinum toxin for drooling in Parkinson\u27s disease
, 2016 \ua9 2016 The Cochrane Collaboration.This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: Primary objective: to assess the efficacy of botulinum toxin treatment to reduce or eliminate drooling in adults with Parkinson ...
Hill F +5 more
core
Pseudo Intestinal Occlusion: Case Report and Literature Review
Revista Médica del Hospital General de México, 2014 Introduction: Chronic intestinal pseudo-obstruction is a rare but severe disease. Often passes unrecognized for long time. Case Report: 75-year-old Hispanic male with a history of Parkinson ́s disease, Diabetes Mellitus Type 2 and Chronic Arterial ...
Mariel González-Calatayud +1 more
doaj +1 more source
Journal of Parkinson’s Disease, 2020 Background: Parkinson’s disease (PD) is often associated with psychological distress and lowered daily functioning. The availability of psychological interventions tailored for people with Parkinson is very limited.
Martin Kraepelien +8 more
doaj +1 more source
Advanced Science, EarlyView.This study presents a miniaturized bidirectional thermal stimulation system integrated with an electrode array enabling real‐time, bidirectional modulation and simultaneous recording of neural activity through localized heating and cooling. By monolithic integration of the Peltier element and with a silicon neural probe, the innovative system allows ...
Zoia Naumkina +6 more
wiley +1 more source
Toward understanding ambulatory activity decline in Parkinson disease [PDF]
, 2015 BACKGROUND: Declining ambulatory activity represents an important facet of disablement in Parkinson disease (PD). OBJECTIVE: The primary study aim was to compare the 2-year trajectory of ambulatory activity decline with concurrently evolving facets of ...
Ford, Matthew P. +5 more
core +1 more source
Smart Nanotechnologies for Multimodal Neuromodulation and Brain Interfacing
Advanced Science, EarlyView.Recent advances in smart nanotechnologies are expanding the toolbox for brain interfacing, from wireless neuromodulation and high‐resolution sensing to targeted delivery within the central nervous system. By combining responsive nanomaterials with bioinspired design, these platforms enable multimodal interactions with neurons and glia, while also ...
Tommaso Curiale +6 more
wiley +1 more source
Convergence insufficiency in idiopathic Parkinson\u27s disease responsive to levodopa
, 1999 We report a patient with pathologically proven idiopathic Parkinson\u27s disease (IPD) who developed diplopia secondary to convergence insufficiency during his motor off periods. Diplopia resolved with onset of motor benefit from levodopa.
Perlmutter, J S +3 more
core +1 more source
, 2022 Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, affecting 1–2% of the population older than 60 years. It is characterized by a variety of motor and non-motor symptoms, which are secondary to degeneration of dopaminergic ...
Nur Aini
core +1 more source
Patient Preference and Adherence, 2014 Li Wei,1,2 Yinghui Chen1,2 1Department of Neurology, Jinshan Hospital, 2Department of Neurology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China Abstract: Neuroleptic malignant-like syndrome (NMLS) is a rare but ...
Wei L, Chen Y
doaj
Advanced Science, EarlyView.STAU2 undergoes phase separation to form dynamic condensates that package target mRNAs and deliver them to the distal ends of growing neuronal dendrites. STAU2 condensates stabilize embedded mRNAs and repress their translation. Synaptic activity bidirectionally remodels STAU2 condensates, coordinating local translation of STAU2‐associated mRNAs ...
Shijing Huang +8 more
wiley +1 more source